Showing results (41-50 of 229) with videos related to
Sort By:
Pageof 23
RSC Medicinal Chemistry|May 8, 2025
New Trypanosoma brucei acting derivatives incorporating 1-(4-phenyl)adamantane and 1-(4-phenoxyphenyl)adamantaneKonstantina Stavropoulou, Angeliki Kaimaki, Maria Nikolaou, et al.Pharmaceuticals (Basel, Switzerland)|July 29, 2023
Novel Lipophilic Hydroxamates Based on Spirocarbocyclic Hydantoin Scaffolds with Potent Antiviral and Trypanocidal ActivityVasiliki Pardali, Erofili Giannakopoulou, George Mpekoulis, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|September 1, 2018
Synthesis, anti-bacterial and anti-protozoal activities of amidinobenzimidazole derivatives and their interactions with DNA and RNAAndrea Bistrović, Luka Krstulović, Ivana Stolić, et al.The Journal of Infectious Diseases|May 4, 2012
Benznidazole-resistance in Trypanosoma cruzi is a readily acquired trait that can arise independently in a single populationAna Maria Mejia, Belinda S Hall, Martin C Taylor, et al.Cellular Microbiology|April 10, 2014
Bioluminescence imaging of chronic Trypanosoma cruzi infections reveals tissue-specific parasite dynamics and heart disease in the absence of locally persistent infectionMichael D Lewis, Amanda Fortes Francisco, Martin C Taylor, et al.Current Pharmaceutical Design|February 11, 2020
Lipophilic Guanylhydrazone Analogues as Promising Trypanocidal Agents: An Extended SAR StudyVasiliki Pardali, Erofili Giannakopoulou, Dimitrios-Ilias Balourdas, et al.Medchemcomm|July 16, 2019
Scaffold hybridization strategy towards potent hydroxamate-based inhibitors of Flaviviridae viruses and Trypanosoma speciesErofili Giannakopoulou, Vasiliki Pardali, Efseveia Frakolaki, et al.Scientific Reports|November 2, 2017
Genome-wide mutagenesis and multi-drug resistance in American trypanosomes induced by the front-line drug benznidazoleMônica C Campos, Jody Phelan, Amanda F Francisco, et al.Methods in Molecular Biology (Clifton, N.J.)|March 15, 2019
Exploiting Genetically Modified Dual-Reporter Strains to Monitor Experimental Trypanosoma cruzi Infections and Host-Parasite InteractionsMartin C Taylor, Amanda F Francisco, Shiromani Jayawardhana, et al.Current Pharmaceutical Design|November 25, 2020
Bioluminescent:Fluorescent Trypanosoma cruzi Reporter Strains as Tools for Exploring Chagas Disease Pathogenesis and Drug ActivityMartin C Taylor, Alexander I Ward, Francisco Olmo, et al.Pageof 23